Connect with us

Hi, what are you looking for?

Jewish Business News


Teva launches generic blood pressure treatment in US


Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced : the Food and Drug Administration (FDA) approval and the launch of the generic equivalent of Diovan (Valsartan) tablets in the US. Diovan treats high blood pressure and is used by heart disease patients.

Diovan, marketed by Novartis Pharmaceuticals, had annual sales of about $1.8 billion in the US, according to IMS data as of October 2014.

Yesterday, Teva announced the launch of two new generic versions of antibiotics in the US.




You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.